January 21, 2026
through
January 22, 2026
Paris Expo, Porte de Versailles – Hall 4 | Paris, France
Sterigenics is happy to announce will be exhibiting with Nelson Labs at the Pharmapack tradeshow in Paris France, January 21-22, 2026. Pharmapack – Europe’s leading packaging and drug delivery event is where the world of pharma meets in one place.
Our team members and industry experts will be available to answer your complex questions to meet your business needs. Stop by booth, 4D17, for a complimentary, one-on-one consultation. Register for Pharmapack today: www.pharmapackeurope.com
For details about the different lectures, refer to the information provided below:
| Thursday, January 22, 2026 |
Extractables and Leachables for Combination Products
A significant part of recent pharmaceutical products are combination devices, for which the packaging also serves as delivery system for the drug product to the patient. Impurities may be released from these polymeric systems (extractables) and may end up in the drug product (leachables) and as such pose a safety risk to the patient. In this presentation, an overview of different types of combination devices will be given, followed by a discussion on the importance of extractables and leachables testing. The regulatory landscape (and relevant guidelines) will be discussed for both EU and US markets. Lastly, relevant parameters for these studies such as extraction time, temperature and extraction solvents will be reviewed, while these will also be demonstrated in a practical case study
Pieter Van Wouwe
Scientific Expert, Nelson Labs
| Thursday, January 22, 2026 |
Optimizing Ethylene Oxide Sterilization: Sustainable Solutions for Pharmaceutical Packaging and Drug Delivery Devices
Ethylene oxide (EO) remains the sterilization method of choice for approximately 50% of all single-use medical devices worldwide, thanks to its excellent material compatibility and scalability. As the industry advances toward more sustainable practices, innovative optimization strategies are helping reduce EO use while maintaining required sterility assurance levels (SAL) to help ensure patient safety.
Presented in partnership with Sterigenics and Gerresheimer
Stefan Reisbacher
Technical Advisor Sterigenics
Bernd Zeiss
Head of Scientific Affairs and Application Technologies, Gerresheimer
